You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

1

Eliquis?

See the DrugPatentWatch profile for eliquis

The Comprehensive Guide to Eliquis: Understanding its Mechanism, Benefits, and Risks

Eliquis, also known as apixaban, is a prescription medication used to prevent and treat blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Developed by Pfizer and Bristol-Myers Squibb, Eliquis has become a popular choice among healthcare professionals due to its effectiveness and relatively low risk of bleeding compared to other anticoagulants.

What is Eliquis Used For?

Eliquis is primarily used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, a condition characterized by an irregular heartbeat. It is also used to treat deep vein thrombosis and pulmonary embolism, which occur when blood clots form in the legs or lungs, respectively.

How Does Eliquis Work?

Eliquis works by inhibiting the activity of factor Xa, a protein involved in the blood clotting process. By blocking factor Xa, Eliquis prevents the formation of blood clots and reduces the risk of stroke and other complications associated with atrial fibrillation.

Benefits of Eliquis

Eliquis has several benefits that make it an attractive option for patients with atrial fibrillation and other blood clotting disorders. Some of the key benefits include:

* Effective in preventing stroke and systemic embolism: Eliquis has been shown to be effective in reducing the risk of stroke and systemic embolism in patients with atrial fibrillation.
* Low risk of bleeding: Compared to other anticoagulants, Eliquis has a relatively low risk of bleeding, making it a safer option for patients.
* Convenient dosing: Eliquis is taken orally, once or twice daily, depending on the patient's condition and other medications they may be taking.
* Well-tolerated: Eliquis is generally well-tolerated, with a low incidence of side effects.

Risks and Side Effects of Eliquis

While Eliquis is generally safe and effective, it can cause some side effects and interact with other medications. Some of the common risks and side effects include:

* Bleeding: Eliquis can increase the risk of bleeding, particularly in patients with a history of bleeding disorders or taking other medications that thin the blood.
* Allergic reactions: Some patients may experience allergic reactions to Eliquis, including hives, itching, and difficulty breathing.
* Gastrointestinal problems: Eliquis can cause stomach upset, nausea, and diarrhea in some patients.
* Interactions with other medications: Eliquis can interact with other medications, including warfarin, aspirin, and other anticoagulants.

Who Should Not Take Eliquis?

Eliquis is not suitable for everyone, particularly those with certain medical conditions or taking other medications. Some of the patients who should not take Eliquis include:

* Pregnant or breastfeeding women: Eliquis can harm the fetus or baby, so it is not recommended for pregnant or breastfeeding women.
* Patients with bleeding disorders: Eliquis can increase the risk of bleeding in patients with bleeding disorders, such as hemophilia.
* Patients taking other anticoagulants: Eliquis can interact with other anticoagulants, such as warfarin, and increase the risk of bleeding.

Dosage and Administration of Eliquis

Eliquis is taken orally, once or twice daily, depending on the patient's condition and other medications they may be taking. The recommended dosage is as follows:

* Non-valvular atrial fibrillation: 5 mg twice daily
* Deep vein thrombosis and pulmonary embolism: 10 mg twice daily for the first 7-10 days, followed by 5 mg twice daily

Cost and Availability of Eliquis

Eliquis is a prescription medication, and its cost can vary depending on the patient's insurance coverage and location. According to DrugPatentWatch.com, the patent for Eliquis expired in 2024, which may lead to generic versions becoming available and reducing the cost of the medication.

Conclusion

Eliquis is a prescription medication used to prevent and treat blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Its effectiveness and relatively low risk of bleeding make it a popular choice among healthcare professionals. However, it is essential to discuss the benefits and risks of Eliquis with a healthcare professional before starting treatment.

Key Takeaways

* Eliquis is used to prevent and treat blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism.
* Eliquis works by inhibiting the activity of factor Xa, a protein involved in the blood clotting process.
* Eliquis has a relatively low risk of bleeding compared to other anticoagulants.
* Eliquis is taken orally, once or twice daily, depending on the patient's condition and other medications they may be taking.
* Eliquis can interact with other medications, including warfarin, aspirin, and other anticoagulants.

Frequently Asked Questions

1. Q: What is Eliquis used for?
A: Eliquis is used to prevent and treat blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism.
2. Q: How does Eliquis work?
A: Eliquis works by inhibiting the activity of factor Xa, a protein involved in the blood clotting process.
3. Q: What are the benefits of Eliquis?
A: Eliquis has several benefits, including its effectiveness in preventing stroke and systemic embolism, low risk of bleeding, convenient dosing, and well-tolerated side effects.
4. Q: What are the risks and side effects of Eliquis?
A: Eliquis can cause bleeding, allergic reactions, gastrointestinal problems, and interact with other medications.
5. Q: Who should not take Eliquis?
A: Eliquis is not suitable for pregnant or breastfeeding women, patients with bleeding disorders, and patients taking other anticoagulants.

Sources

1. DrugPatentWatch.com: Eliquis (apixaban) patent expiration date.
2. Pfizer: Eliquis (apixaban) product information.
3. Bristol-Myers Squibb: Eliquis (apixaban) product information.
4. National Institutes of Health: Atrial fibrillation treatment options.
5. American Heart Association: Deep vein thrombosis and pulmonary embolism treatment options.

Note: The information provided in this article is for educational purposes only and should not be considered as medical advice. Patients should consult with their healthcare professional before starting treatment with Eliquis or any other medication.



Other Questions About Eliquis :  When does the patent on Eliquis run out? When will eliquis paten expire? Are there any discounts available for eliquis?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy